Evidence map›Paper›PMID 33322712›Full record

ArticleMolecules (Basel, Switzerland)2020

The Anti-Cancer Effect of Linusorb B3 from Flaxseed Oil through the Promotion of Apoptosis, Inhibition of Actin Polymerization, and Suppression of Src Activity in Glioblastoma Cells.

Nak Yoon Sung, Deok Jeong, Youn Young Shim, Zubair Ahmed Ratan, Young-Jin Jang, Martin J T Reaney, Sarah Lee, Byoung-Hee Lee, Jong-Hoon Kim, Young-Su Yi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Anti-Oxidant and Anti-Cancer Properties of Flaxseed.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Nak Yoon SungDepartment of Integrative Biotechnology, Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.
Deok JeongDepartment of Integrative Biotechnology, Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0001-9092-9662
Youn Young ShimDepartment of Integrative Biotechnology, Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0002-5039-8219
Zubair Ahmed RatanDepartment of Biomedical Engineering, Khulna University of Engineering and Technology, Khulna 9203, Bangladesh.ORCID 0000-0002-4820-7540
Young-Jin JangCollege of Veterinary Medicine, Chonbuk National University, Iksan 54596, Korea.
Martin J T ReaneyDepartment of Plant Sciences, University of Saskatchewan, Saskatoon, SK S7N 5A8, Canada.
Sarah LeeNational Institute of Biological Resources, Environmental Research Complex, Incheon 22689, Korea.
Byoung-Hee LeeNational Institute of Biological Resources, Environmental Research Complex, Incheon 22689, Korea.
Jong-Hoon KimCollege of Veterinary Medicine, Chonbuk National University, Iksan 54596, Korea.
Young-Su YiDepartment of Life Sciences, Kyonggi University, Suwon 16227, Korea.ORCID 0000-0002-7166-3659
Jae Youl ChoDepartment of Integrative Biotechnology, Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0001-8141-9927
Sungkyunkwan University · KRJeonbuk National University · KRNational Institute of Biological Resources · KRUniversity of Saskatchewan · CAKhulna University of Engineering and Technology · BDKyonggi University · KR

Funding

National Research Foundation of Korea 2015K2A1A2070737National Research Foundation of Korea 2017R1A6A1A03015642National Research Foundation of Korea 2019H1D3A2A01102248
6 · The paper itself

Abstract

Linusorbs (LOs) are natural peptides found in flaxseed oil that exert various biological activities. Of LOs, LOB3 ([1-9-NαC]-linusorb B3) was reported to have antioxidative and anti-inflammatory activities; however, its anti-cancer activity has been poorly understood. Therefore, this study investigated the anti-cancer effect of LOB3 and its underlying mechanism in glioblastoma cells. LOB3 induced apoptosis and suppressed the proliferation of C6 cells by inhibiting the expression of anti-apoptotic genes, B cell lymphoma 2 (Bcl-2) and p53, as well as promoting the activation of pro-apoptotic caspases, caspase-3 and -9. LOB3 also retarded the migration of C6 cells, which was achieved by suppressing the formation of the actin cytoskeleton critical for the progression, invasion, and metastasis of cancer. Moreover, LOB3 inhibited the activation of the proto-oncogene, Src, and the downstream effector, signal transducer and activator of transcription 3 (STAT3), in C6 cells. Taken together, these results suggest that LOB3 plays an anti-cancer role by inducing apoptosis and inhibiting the migration of C6 cells through the regulation of apoptosis-related molecules, actin polymerization, and proto-oncogenes.

Indexed as

ActinsAntineoplastic Agents, PhytogenicApoptosisBrain NeoplasmsCaspasesCell Line, TumorCell MovementDrug Delivery SystemsEnzyme ActivationGlioblastomaHumansLinseed OilOncogene Protein pp60(v-src)PolymerizationProto-Oncogene MasSTAT3 Transcription FactorActinsAntineoplastic Agents, PhytogenicCaspasesLinseed OilMAS1 protein, humanOncogene Protein pp60(v-src)Proto-Oncogene MasSTAT3 protein, humanSTAT3 Transcription Factoractin polymerizationanti-cancerapoptosisFlaxseed oilglioblastomalinusorb B3Src

Identifiers

PMID33322712
PMCPMC7764463
OpenAlexW3112862977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.